In this study, IGF‐1 treatment activated PI3K‐Akt‐mTOR signalling pathway, enlarged the resistance to radiotherapy, and elevated glucose uptake and the expression of HIF‐1α and Glut‐1 in laryngeal cancer cells. This evidence concerns the gene AKT1 and laryngeal carcinoma.